Amanta Healthcare Rs 126 Crore IPO From Sept.1
25 Aug 2025 2:03 PM IST25 Aug 2025 2:03 PM IST
Amanta is a Hariyala, Gujarat based midsize company and a contract manufacturing partner for leading pharmaceutical companies outsourcing their products
Representational Image
Mumbai: Pharmaceutical company Amanta Healthcare engaged in manufacture of IV Fluids and other injectables announced Rs 126 crore initial public offering in the price band of Rs 120 to Rs 126 per equity share of Rs 10 face value. The public issue of Amanta opens on Sept.1 and closes on Sept. 3, 2025.
Amanta is a Hariyala, Gujarat based midsize company and a contract manufacturing partner for leading pharmaceutical companies outsourcing their products.
The public issue is entirely a fresh issue of equity shares and the money raised will be used for funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort(IV Fluid Container) and another manufacturing line for SVP(small volume parenteral) at Hariyala.
Founded in 1997, Amanta Healthcare started as IV(intravenous)fluids manufacturer and now also manufactures formulations and injectables. Company specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products.
( Source : Deccan Chronicle )
Next Story